First human test of new Huntington's disease injection begins

NCT ID NCT06024265

Summary

This early study tested a new drug called ER2001, given by IV injection, in 10 adults with early Huntington's disease. The main goal was to check the safety of different doses and see how the drug moves through the body. Researchers also looked for early signs that the drug might be working to help control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, 510080, China

Conditions

Explore the condition pages connected to this study.